KEVIN P STARR Insider Trading $CTMX CytomX Therapeutics, Inc.
Get free email notifications about insider trading for KEVIN P STARR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN P STARR. KEVIN P STARR is Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in ZAFGEN, INC. ($ZFGN) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and in Sage Therapeutics, Inc. ($SAGE) and Director in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and Director in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Editas Medicine, Inc. ($EDIT).
KEVIN P STARR in CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR: 10% Owner
Holdings: 31,419 shares
Current Value: $361,319
Latest Transaction: Apr 14 2017
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KEVIN P STARR in CytomX Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, BPMC, CTMX, EDIT, GBT, LRMR, MYOK, SAGE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 2017 | CTMX | CytomX Therapeutic ... | STARR KEVIN P | 10% Owner | Sell | S | 16.36 | 28,357 | 463,793 | 31,419 | 59.8 K to 31.4 K (-47.44 %) |
Page: 1